Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- C3569 SW203668Summary: stearoyl CoA desaturase inhibitor
- C3620 CUDASummary: Soluble epoxide hydrolase (sEH) inhibitor
- C5081 Bromoenol lactoneSummary: Inhibitor of myocardial cytosolic calcium-independent phospholipase A2 (iPLA2)
- C3919 VU0359595Summary: PLD1 inhibitor
- C4030 (3S,5S)-Atorvastatin (sodium salt)Summary: negetive control of Atorvastatin, HMG-CoA reductase inhibitor
- C3106 Pargyline (hydrochloride)Summary: MAO inhibitor
- C3986 MuraglitazarSummary: dual agonist of PPARα and PPARγ
- C3827 L-CanalineSummary: aminotransferases inhibitor
- B7841 CAY10499Summary: inhibitor of human hormone sensitive lipase
- C4696 Ebselen